Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms. [electronic resource]
- Molecular diagnosis & therapy Oct 2012
- 269-83 p. digital
Publication Type: Journal Article; Review
1179-2000
10.1007/s40291-012-0006-3 doi
Adaptor Proteins, Signal Transducing Alleles Benzamides--therapeutic use Bridged-Ring Compounds--therapeutic use Carbazoles--therapeutic use Chromatin--genetics DNA (Cytosine-5-)-Methyltransferases--genetics DNA Methyltransferase 3A DNA-Binding Proteins--genetics Dioxygenases Enhancer of Zeste Homolog 2 Protein Epigenesis, Genetic Furans Gene Expression Regulation Humans Ikaros Transcription Factor--genetics Intracellular Signaling Peptides and Proteins Isocitrate Dehydrogenase--genetics Janus Kinase 2--antagonists & inhibitors Mutation Myeloproliferative Disorders--genetics Nitriles Polycomb Repressive Complex 2--genetics Proteins--genetics Proto-Oncogene Proteins--genetics Proto-Oncogene Proteins c-cbl--genetics Pyrazoles--therapeutic use Pyrimidines--therapeutic use Pyrrolidines--therapeutic use Receptors, Thrombopoietin--genetics Repressor Proteins--genetics Signal Transduction Spliceosomes--metabolism Sulfonamides--therapeutic use